INGN
Price
$6.81
Change
+$0.01 (+0.15%)
Updated
Jul 25, 04:59 PM (EDT)
Capitalization
176.12M
13 days until earnings call
INSP
Price
$129.00
Change
+$0.36 (+0.28%)
Updated
Jul 25, 04:59 PM (EDT)
Capitalization
6.35B
10 days until earnings call
Interact to see
Advertisement

INGN vs INSP

Header iconINGN vs INSP Comparison
Open Charts INGN vs INSPBanner chart's image
Inogen
Price$6.81
Change+$0.01 (+0.15%)
Volume$3.18K
Capitalization176.12M
Inspire Medical Systems
Price$129.00
Change+$0.36 (+0.28%)
Volume$981
Capitalization6.35B
INGN vs INSP Comparison Chart in %
Loading...
INGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INGN vs. INSP commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INGN is a Buy and INSP is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2025
Stock price -- (INGN: $6.80 vs. INSP: $128.64)
Brand notoriety: INGN and INSP are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: INGN: 123% vs. INSP: 94%
Market capitalization -- INGN: $176.12M vs. INSP: $6.35B
INGN [@Medical Specialties] is valued at $176.12M. INSP’s [@Medical Specialties] market capitalization is $6.35B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INGN’s FA Score shows that 0 FA rating(s) are green whileINSP’s FA Score has 0 green FA rating(s).

  • INGN’s FA Score: 0 green, 5 red.
  • INSP’s FA Score: 0 green, 5 red.
According to our system of comparison, both INGN and INSP are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INGN’s TA Score shows that 5 TA indicator(s) are bullish while INSP’s TA Score has 5 bullish TA indicator(s).

  • INGN’s TA Score: 5 bullish, 5 bearish.
  • INSP’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, INSP is a better buy in the short-term than INGN.

Price Growth

INGN (@Medical Specialties) experienced а +1.80% price change this week, while INSP (@Medical Specialties) price change was +0.52% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +2.87%. For the same industry, the average monthly price growth was +4.89%, and the average quarterly price growth was -2.72%.

Reported Earning Dates

INGN is expected to report earnings on Nov 05, 2025.

INSP is expected to report earnings on Nov 04, 2025.

Industries' Descriptions

@Medical Specialties (+2.87% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INSP($6.35B) has a higher market cap than INGN($176M). INGN YTD gains are higher at: -25.845 vs. INSP (-30.607). INSP has higher annual earnings (EBITDA): -17.06M vs. INGN (-58.34M). INSP has more cash in the bank: 460M vs. INGN (128M). INGN has less debt than INSP: INGN (21.9M) vs INSP (24.8M). INSP has higher revenues than INGN: INSP (625M) vs INGN (316M).
INGNINSPINGN / INSP
Capitalization176M6.35B3%
EBITDA-58.34M-17.06M342%
Gain YTD-25.845-30.60784%
P/E Ratio71.43N/A-
Revenue316M625M51%
Total Cash128M460M28%
Total Debt21.9M24.8M88%
FUNDAMENTALS RATINGS
INGN vs INSP: Fundamental Ratings
INGN
INSP
OUTLOOK RATING
1..100
7256
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
77
Overvalued
PROFIT vs RISK RATING
1..100
10080
SMR RATING
1..100
9365
PRICE GROWTH RATING
1..100
6464
P/E GROWTH RATING
1..100
63100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

INSP's Valuation (77) in the Medical Specialties industry is in the same range as INGN (83). This means that INSP’s stock grew similarly to INGN’s over the last 12 months.

INSP's Profit vs Risk Rating (80) in the Medical Specialties industry is in the same range as INGN (100). This means that INSP’s stock grew similarly to INGN’s over the last 12 months.

INSP's SMR Rating (65) in the Medical Specialties industry is in the same range as INGN (93). This means that INSP’s stock grew similarly to INGN’s over the last 12 months.

INSP's Price Growth Rating (64) in the Medical Specialties industry is in the same range as INGN (64). This means that INSP’s stock grew similarly to INGN’s over the last 12 months.

INGN's P/E Growth Rating (63) in the Medical Specialties industry is somewhat better than the same rating for INSP (100). This means that INGN’s stock grew somewhat faster than INSP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
INGNINSP
RSI
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 4 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 3 days ago
72%
Bullish Trend 16 days ago
86%
Declines
ODDS (%)
Bearish Trend 10 days ago
82%
Bearish Trend 10 days ago
75%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
70%
Bearish Trend 2 days ago
62%
Aroon
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
INGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FAIRX32.83N/A
N/A
Fairholme
GGICX13.16N/A
N/A
Goldman Sachs Global Infras C
GIDWX17.94N/A
N/A
Goldman Sachs US Eq Div and Premium R6
EQIIX13.51N/A
N/A
Allspring Emerging Markets Eq Advtg Inst
RSEBX70.69-0.44
-0.62%
American Funds SMALLCAP World R2E

INGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, INGN has been loosely correlated with VCYT. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if INGN jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INGN
1D Price
Change %
INGN100%
+7.26%
VCYT - INGN
47%
Loosely correlated
-2.56%
STRRP - INGN
44%
Loosely correlated
N/A
OSUR - INGN
38%
Loosely correlated
+0.61%
ITGR - INGN
35%
Loosely correlated
-7.49%
INSP - INGN
33%
Poorly correlated
-2.21%
More

INSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, INSP has been loosely correlated with TMCI. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if INSP jumps, then TMCI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INSP
1D Price
Change %
INSP100%
-2.21%
TMCI - INSP
54%
Loosely correlated
-4.77%
MASI - INSP
48%
Loosely correlated
-2.19%
VCYT - INSP
40%
Loosely correlated
-2.56%
ALGN - INSP
34%
Loosely correlated
-0.96%
RMD - INSP
34%
Loosely correlated
+0.05%
More